您現在的位置 :

醫療團隊

專業的醫護人員，提供最佳的醫療服務

醫師介紹

  •

陳枻志醫師

1.思覺失調症 2.情感疾患 3.焦慮、失眠合併自律神經失調 4.酒藥癮戒治
  • 國語,英語,閩南語
醫師網路掛號
直接點選進入醫師網路掛號畫面
醫師資歷
  • 現職
    • 基隆長庚紀念醫院精神科助理教授級主治醫師
    • 基隆長庚紀念醫院員工諮商委員會委員
  • 學歷
    • 英國倫敦大學精神病研究所進修
    • 陽明大學醫學院醫學士
  • 經歷
    • 英國倫敦大學國王學院精神病研究所進修
    • 基隆長庚醫院精神科住院醫師
    • 基隆長庚醫院精神科總醫師
    • 基隆長庚醫院精神科住院醫師
  • 學會與認證
    • 精神科專科醫師
    • 成癮次專科醫師
    • 台灣兒童青少年精神醫學會會員
  • 論文及期刊發表
    • Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users.
      J Psychoactive Drugs. 2015 Sep-Oct;47(4):317-24.
      Chen YC, Chen CK, Wang LJ.
    • Predictors of Relapse and Dropout During a 12-Week Relapse Prevention Program for Methamphetamine Users.
      Journal of Psychoactive Drugs, 47 (4), 317–324, 2015
      Yi-Chih Chen, Chih-Ken Chen, Liang-Jen Wang.
    • Neurocognitive Profiles of Methamphetamine Users: Comparison of Those With or Without Concomitant Ketamine Use.
      Substance Use and Misuse. 2015;50:1778–1785.(SCI; IF=1.234; Psychiatry 103/140)
      Chen YC, Wang LJ, Lin SK, Chen CK*.
    • Predictors of Relapse and Dropout During a 12-week Relapse Prevention Program for Methamphetamine Users.
      Journal of Psychoactive Drugs. 2015; 47 (4), 317–324. (SCI; IF=1.308)
      Chen YC, Chen CK , Wang LJ*.
    • Persistence of psychotic symptoms as an indicator of cognitive impairment in methamphetamine users.
      Drug Alcohol Depend. 2015 Mar 1;148:158-64. (SCI; IF=3.423; Psychiatry 41/140)
      Chen CK, Lin SK, Chen YC, Huang MC, Chen TT, Ree SC, Wang LJ*.
    • Trends in anxiolytic-hypnotic use and polypharmacy in Taiwan, 2002-2009: a nationwide, population-based survey.
      Psychiatr Serv. 2014 Feb 1;65(2):208-14. (SCI; IF=2.412; Psychiatry 64/140)
      Wang LJ*, Chen YC, Chen CK, Chou WJ, Chou MC.
    • Health care service utilization and associated factors among heroin users in northern Taiwan.
      Addictive Behaviors. 2013; 38(11):2635-2638. (SCI; IF=2.764; Substance Abuse 7/19)
      Chen YC, Chen CK , Lin SK, Chiang SC, Su LW, Wang LJ*.
    • Quetiapine Fumarate Augmentation for Patients with a Primary Anxiety Disorder or a Mood Disorder: a Pilot Study.
      BMC Psychiatry. 2012 Sep,12:162. (SCI; IF=2.552; Psychiatry 54/129)
      Chen YC, Chen CK*, Wang LJ.
    • Association of Salivary Dehydoepiandrosterone Levels and Symptoms in Patients with Attention Deficit Hyperactivity Disorder during Six Months of Treatment with Methylphenidate.
      Psychoneuroendocrinology 2011;36(8):1209-1216. (SCI; IF=5.809; Psychiatry 12/129)
      Wang LJ, Hsiao CC, Huang YS, Chiang YL, Ree SC, Chen YC, Wu YW, Wu CC, Shang ZY, Chen CK*.
    • Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α-induced Depresion by Regulating Polyunsaturated Fatty Acids Levels.
      Biol Psychiatry 2010;67:550-557. (SCI; IF=8.283; Psychiatry 5/129)
      Su KP, Huang SY, Peng CY, Lai HC, Huang CL, Chen YC, Aitchison KJ, Pariante CM*.
    • The Potential Risk Factors of Methadone Maintenance Therapy-A Mortality Case Report.
      Formosa Journal of Clinical Pharmacy. 2010;18(2):47-60.
      Lo CY, Lin YC, Chen YC, Chen YH*.
    • Clinical Effectiveness of Group Cognitive-behavioral Therapy for Primary and Secondary Insomnia.
      Taiwanese Journal of Psychiatry 2009;23:207-14.
      Chen YC, Huang YS, Chen CK*.
    • Effects of a 10-week weight control program on obese patients with schizophrenia or schizoaffective disorder; a 12-month follow-up.
      Psychiatry Clin Neurosci. 2009 Feb;63(1):17-22. (SCI; IF=2.133; Psychiatry 71/129)
      Chen CK, Chen YC, Huang YS*.